Columbia University

Technology Ventures

TRx and CTV Translational Therapeutics Seminar: Rethinking Academic Drug Discovery and Development

April 24, 2017
Michael Foley, PhD
Irving Institute (PH10-405)
622 W. 168th Street, 10th floor
New York, NY

The TRx pilot award is designed to provide education, mentorship, and funding to accelerate early-stage therapy discovery towards the clinic. The Translational Therapeutics Seminar Series is a 6-part series which will include speakers with varying perspectives on the drug development process, ranging from an academic investigator’s experiences to an industry investor’s perspective. 

Part one of the series features Dr. Michael Foley, renouned chemist, entrepreneur, and Director of the Tri-Institutional Therapeutics Discovery Institute, a partnership between The Rockefeller University, Memorial Sloan Kettering Cancer Center ,Weill Cornell Medicine  and Takeda focused on the discovery of next-generation drugs. 

For more information, please contact Maria Rahmany at